Literature DB >> 21969506

Implications of the oropharyngeal cancer epidemic.

Edmund A Mroz, Arlene A Forastiere, James W Rocco.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21969506      PMCID： PMC3607743          DOI： 10.1200/JCO.2011.37.8893

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  24 in total

1.  Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma.

Authors:  Shahnaz Begum; Dengfeng Cao; Maura Gillison; Marianna Zahurak; William H Westra
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

2.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Authors:  Lisa Licitra; Federica Perrone; Paolo Bossi; Simona Suardi; Luigi Mariani; Raffaella Artusi; Maria Oggionni; Chiara Rossini; Giulio Cantù; Massimo Squadrelli; Pasquale Quattrone; Laura D Locati; Cristiana Bergamini; Patrizia Olmi; Marco A Pierotti; Silvana Pilotti
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

3.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 4.  Clinical implications of human papillomavirus in head and neck cancers.

Authors:  Carole Fakhry; Maura L Gillison
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

Review 5.  Head and neck cancer: changing epidemiology, diagnosis, and treatment.

Authors:  Shanthi Marur; Arlene A Forastiere
Journal:  Mayo Clin Proc       Date:  2008-04       Impact factor: 7.616

Review 6.  HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.

Authors:  Maura L Gillison; Anil K Chaturvedi; Douglas R Lowy
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

7.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

8.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

Authors:  Bhavna Kumar; Kitrina G Cordell; Julia S Lee; Francis P Worden; Mark E Prince; Huong H Tran; Gregory T Wolf; Susan G Urba; Douglas B Chepeha; Theodoros N Teknos; Avraham Eisbruch; Christina I Tsien; Jeremy M G Taylor; Nisha J D'Silva; Kun Yang; David M Kurnit; Joshua A Bauer; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

9.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.

Authors:  Maura L Gillison; Gypsyamber D'Souza; William Westra; Elizabeth Sugar; Weihong Xiao; Shahnaz Begum; Raphael Viscidi
Journal:  J Natl Cancer Inst       Date:  2008-03-11       Impact factor: 13.506

10.  Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.

Authors:  Kathleen Settle; Marshall R Posner; Lisa M Schumaker; Ming Tan; Mohan Suntharalingam; Olga Goloubeva; Scott E Strome; Robert I Haddad; Shital S Patel; Earl V Cambell; Nicholas Sarlis; Jochen Lorch; Kevin J Cullen
Journal:  Cancer Prev Res (Phila)       Date:  2009-07-29
View more
  9 in total

1.  Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression.

Authors:  Elisabeth G Vichaya; Jessica M Molkentine; Daniel W Vermeer; Adam K Walker; Rebekah Feng; Gerard Holder; Katherine Luu; Ryan M Mason; Leo Saligan; Cobi J Heijnen; Annemieke Kavelaars; Kathy A Mason; John H Lee; Robert Dantzer
Journal:  Behav Brain Res       Date:  2015-10-22       Impact factor: 3.332

Review 2.  Primary chemotherapy and radiation as a treatment strategy for HPV-positive oropharyngeal cancer.

Authors:  Vivian Wai Yan Lui; Jennifer Rubin Grandis
Journal:  Head Neck Pathol       Date:  2012-07-03

3.  Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas.

Authors:  Daniel L Miller; J Wade Davis; Kristen H Taylor; Jeff Johnson; Zonggao Shi; Russell Williams; Ulus Atasoy; James S Lewis; M Sharon Stack
Journal:  Am J Pathol       Date:  2015-01-05       Impact factor: 4.307

Review 4.  Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

Authors:  Juliana Bonilla-Velez; Edmund A Mroz; Rebecca J Hammon; James W Rocco
Journal:  Otolaryngol Clin North Am       Date:  2013-06-27       Impact factor: 3.346

Review 5.  Role of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.

Authors:  Robbie Woods; Esther M O'Regan; Susan Kennedy; Cara Martin; John J O'Leary; Conrad Timon
Journal:  World J Clin Cases       Date:  2014-06-16       Impact factor: 1.337

6.  Chronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis.

Authors:  Xin Liu; Xiangrui Ma; Zhengge Lei; Hao Feng; Shasha Wang; Xiao Cen; Shiyu Gao; Yaping Jiang; Jian Jiang; Qianming Chen; Yajie Tang; Yaling Tang; Xinhua Liang
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

7.  Prognostic significance of decreased expression of six large common fragile site genes in oropharyngeal squamous cell carcinomas.

Authors:  Ge Gao; Jan L Kasperbauer; Nicole M Tombers; Melissa D Cornell; David I Smith
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

8.  The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting.

Authors:  Stephen F Hall; Rebecca J Griffiths; Brian O'Sullivan; Fei-Fei Liu
Journal:  Head Neck       Date:  2019-02-04       Impact factor: 3.147

9.  The Role of HPV in Determining Treatment, Survival, and Prognosis of Head and Neck Squamous Cell Carcinoma.

Authors:  Imogen Sharkey Ochoa; Esther O'Regan; Mary Toner; Elaine Kay; Peter Faul; Connor O'Keane; Roisin O'Connor; Dorinda Mullen; Mataz Nur; Eamon O'Murchu; Jacqui Barry-O'Crowley; Niamh Kernan; Prerna Tewari; Helen Keegan; Sharon O'Toole; Robbie Woods; Susan Kennedy; Kenneth Feeley; Linda Sharp; Tarik Gheit; Massimo Tommasino; John J O'Leary; Cara M Martin
Journal:  Cancers (Basel)       Date:  2022-09-03       Impact factor: 6.575
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.